skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

89 Total results for product and free and sample content found

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Scrip Asia 100 Report Extract

18 Dec 2019

Access Asia Pharma Intelligence expertise and hear from Pharma journalists across Asia to reveal deep regional expertise with this sample of Scrip's Asia 100 Report.

Trialtrove: 医療用医薬品の臨床試験情報データベース

Trialtrove 2018 Clinical Trials Roundup Surveying the Landscape of 2018 Trial Starts infographic

21 Nov 2019

Trialtrove 2018 Clinical Trials Roundup Surveying the Landscape of 2018 Trial Starts infographic

A clear view of the past is often the surest way to plan for the future. The annual analysis of Phase I-III clinical trials from Citeline’s Trialtrove reveals the priorities and strategies of the biopharma industry. This infographic lets you clearly see the players, trials, and trends.  

Topic drug-development-landscape biopharmaceutical business-strategies

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

オンラインセミナー:NASH治療薬の展望と市場動向

05 Nov 2019

オンラインセミナー:NASH治療薬の展望と市場動向

NASH(非アルコール性脂肪性肝炎)はさらに大きな流行病となりつつあり、あらゆる規模の企業が、業界初のNASH治療薬を市場に出すためにしのぎを削っています。新薬および転用された新薬探索、NASHの治療に関する詳細なディスカッション、およびこの分野のディールメイキング、ライセンスシング、提携戦略についてお聞きください。

Topic cell-and-gene-therapy drug-development-landscape drug-approval

Generics Bulletin: ジェネリック&バイオシミラーニュース

Pfizer Lines Up Trio Of US Biosimilar Launches

01 Nov 2019

Pfizer_Lines_Up_1

By mid-February next year, Pfizer plans to have introduced in the US bevacizumab, rituximab and trastuzumab biosimilars to Avastin, Rituxan and Herceptin.

Topic business-strategies drug-development-landscape

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Interview: AstraZeneca 'Is More Than Oncology'

By sten-stovall 01 Nov 2019

Ruud Dobber oversees AstraZeneca’s biopharmaceuticals division, which generates some 40% of group total revenues. He tells Scrip to “Watch this space.”

Topic Business strategies Drug development landscape

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

GSK's Hal Barron On R&D Progress At Two-Year Mark

By Andrew McConaghie 01 Nov 2019

Chief scientific officer at GSK, Hal Barron, talks about winning hearts and minds of 10,000 R&D employees, and adopting practices from acquired company Tesaro.

Topic business-strategies drug-development-landscape research

Biomedtracker: 開発中医薬品をFDA承認確率で評価, Datamonitor...

2019 Post-ESMO Conference Report Extract

31 Oct 2019

2019 Post-ESMO Conference Report Extract

Tap into insights and highlights from ESMO’s annual meeting of oncology clinicians, researchers, patient advocates, journalists, and members of the pharmaceutical industry.

Topic Cancer Drug development landscape Research

Trialtrove: 医療用医薬品の臨床試験情報データベース

Snapshot of the patient-centric trial landscape

24 Oct 2019

Snapshot of the patient-centric trial landscape

Patient-centric trials have been growing for years. Backed by data from Citeline’s Trialtrove, our latest infographic reveals the trends, the sponsors, and the impact on outcomes around Phase I, II, and III industry-sponsored, patient-centric trials.  

Topic drug-development-landscape

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。